
Veranova, Enzene plot new biologic manufacturing expansions on East Coast
Amid a spate of high-profile investments in U.S. pharmaceutical production, two contract manufacturers are getting in on the action with an emphasis on biologic drugs. First, active pharmaceutical ingredient specialist Veranova is plugging roughly $20 …